KdT Ventures — Full Portfolio

Faeth Therapeutics is a clinical-stage oncology company developing therapies that inhibit multiple nodes of the PI3K/AKT/mTOR (PAM) pathway.

BiotechHealthtechAustin, US

Anand Parikh(Executive Officer, Director, Promoter)Oliver Maddocks(Executive Officer, Director)

BoardAlex Morgan(Director)inJayson Dallas(Director)Robert Gould(Director)Stephen Hahn(Director)

Co-investorsAble PartnersAtacama VenturesCota CapitalFuture VenturesiSelect FundS2G Investments+4 more

Debut applies AI and biotechnology to discover and formulate cosmetic ingredients and beauty products, decoding skin and hair at the genomic level to create novel actives.

AI & Machine LearningBiotechConsumerSan Diego, US

Joshua Britton(Founder)

Co-investorsGS FuturesMaterial ImpactBreakout VenturesSandbox IndustriesACVC PartnersBetter Ventures Central Llc+8 more

Solugen develops a biomanufacturing platform using fermentation and bioprocessing technology to produce specialty chemicals at scale.

Advanced ManufacturingBiotechCleantechClimate TechHealthtechHouston, US

Sean Hunt(Founder/CTO)inGaurab Chakrabarti(Founder)in

BoardSeth Bannon(Director)in

Co-investorsFifty YearsFounders FundLowercarbon CapitalY CombinatorBaillie GiffordGIC+22 more

Andes adds beneficial soil microorganisms alongside agricultural seeds such as corn, soybean, canola, and wheat to accelerate the conversion of atmospheric CO₂ into soil inorganic carbon for durable carbon removal.

AgTechCleantechClimate TechAlameda, US

Board seatPhil Grayeski· per SEC Form D

Co-investorsCavallo VenturesVoyager Partners

Checkerspot uses microalgae precision fermentation to produce specialized lipids and fats, including a bio-equivalent source of the sn-2 palmitate fat found in mother's milk, rare bioactive fatty acids, and tropical fat alternatives.

BiotechClimate TechFoodTechNew MaterialsAlameda, US

Scott Franklin(Executive Officer, Director)Charles Dimmler(Executive Officer, Director)John Krzywicki(CEO)Layla Ward(CFO)Casey Lippmeier(CTO)Leon Parker(SVP, Molecular Biology)

Board seatAndrew Cain McClaryCain McClary· per SEC Form D

Co-investorsBaruch Future VenturesBreakout VenturesCavallo VenturesBuilders VCRefactor Capital

Specialty enzyme solutions combined with continuous manufacturing.

Advanced ManufacturingCarlsbad, US

Joshua Britton(Executive Officer, Director)

BoardCain A. McClary(Director)in

Board seatCain McClary· per SEC Form D · $2.6M raise · filed Jan 2020

Co-investorsCavallo Ventures

Particella, Inc. (formerly DNAlite Therapeutics) is a preclinical biotechnology company developing an oral lipid nanoparticle platform to deliver nucleic acids, such as mRNA, to the intestinal epithelium.

BiotechDeep TechSan Francisco, US

Mubhij Ahmad(Executive Officer, Director)David Rabuka(Director)Timothy Paul Day(Director)

BoardDrew Lanza(Director)

Board seatAndrew Cain McClary· per SEC Form D · $8.9M raise · filed Apr 2022

Co-investorsBerkeley CatalystBlue Bear Ventures

Elegant Bio develops DNA synthesis technology and services, offering ENFINIA™ DNA synthesis at scale for biotech and research applications.

BiotechDeep TechSan Carlos, US

Matthew Hill(Executive Officer, Director)in

BoardPeter Zhou(Director)inJonathan Sheena(Director)

Board seatCain McClary· per SEC Form D

Co-investorsACVC PartnersAndreessen HorowitzRaptor GroupTriatomic CapitalAME Cloud VenturesDigitalis Ventures+1 more

Transcera is a biotech company developing a new class of therapeutics that use lipid trafficking pathways to direct extracellular proteins into lysosomes for degradation, aimed at treating chronic diseases.

BiotechDeep TechBoston, US

Wayne Lencer(Co-Founder & SAB Chair)Hunter Goble(Co-Founder & CEO)Justin Wolfe(Co-Founder & CSO)

Board seatPhil Grayeski· per SEC Form D · $1M raise · filed Jul 2021

Co-investorsPortal InnovationsTau Ventures

STRM.BIO develops a gene therapy delivery platform based on megakaryocyte-derived extracellular vesicles (STRM MVs) that target and deliver genetic cargoes preferentially to bone marrow and hematopoietic stem cells.

BiotechDeep TechMedical Devices

Co-investorsAscension VenturesBreakout LabsBreakout VenturesDelos CapitalNYBC Ventures

Abridge builds AI software that converts clinical conversations into structured insights for healthcare providers.

AI & Machine LearningDigital HealthHealthtechPhiladelphia, US

Shiv Rao(Founder & CEO)Shiv (Shivdev) Rao(Founder)inJulia Chapin(Executive Officer)Sagar Sanghvi(Executive Officer)

BoardAndy Weissman(Director)inSebastian Duesterhoeft(Director)in

Co-investorsAlpha Square Groupalphabet angelsAndreessen HorowitzBessemer Venture PartnersCapitalGCatalio Capital Management, LP+20 more

Aperiam Bio uses computer-vision algorithms to identify "hyperfolding" protein variants with improved expression, solubility, and stability, aiming for order-of-magnitude gains in protein performance.

AI & Machine LearningBiotechDeep TechAustin, US

Austin Cole(CEO & Founder)Guillaume Cottarel(Head of Program)Russell Durrett(Chief Business Officer)

Co-investorsCivilization Ventures Management, LlcOMX VenturesAxial VC

Braid Health combines AI imaging copilots with board-certified radiologists to provide second opinions on MRI, CT, and ultrasound scans, along with AI-generated explanations and workflow tools.

AI & Machine LearningDigital HealthHealthtech

Kevin Quennesson(Founder)in

Co-investorsBronze InvestmentsJazzya InvestmentsLux CapitalMyelin VC

Canaery (now General Sense) is developing scent-detection technology aimed at extending capabilities beyond the limits of human olfactory perception.

Deep TechHardware

Co-investors15th RockGood News VenturesBreakout VenturesDolby Family Ventures

Character Bio is a precision medicine company that integrates genomics, longitudinal clinical data, imaging, and AI-based biomarker analysis to identify genetic drivers of progressive polygenic eye diseases such as age-related macular degeneration and glaucoma.

AI & Machine LearningBiotechDigital HealthJersey City, US

Cheng Zhang(Executive Officer, Director)

BoardVivek Garipalli(Director)Nick Olsen(Director)Peter DiLaura(Director)

Co-investorsaMoonCantos VenturesCatalio Capital Management, LPDuke Capital PartnersLifeforce CapitalSanofi Ventures+3 more

Creasallis develops CreaTap, a patented "plug-and-play" antibody modification technology that improves the penetration of antibody-based drugs into solid tumours, applicable to monoclonal, bispecific, and antibody-drug conjugates.

Biotech

Zahra Jawad(Founder)

Co-investorsBlueYard CapitalPace VenturesZAKA VC

Co-investorsBetter Ventures Central LlcBlue Bear VenturesSafar Partners

Dimension Bio is a biotechnology company that designs and manufactures regenerative therapeutics using its BioNidum™ platform to restore tissue function lost to disease, trauma, or aging.

BiotechHealthtechNew MaterialsChicago, US

Caralynn Nowinski Collens, M.D.(Co-founder & CEO)Ramille Shah, Ph.D.(Co-founder & CSO)Ramille Shah(Director)Caralynn Collens(Executive Officer, Director)

BoardRima Chakrabarti(Director)in

Co-investorsBetter Ventures Central LlcLofty VenturesPathway BioventuresPortal InnovationsSolas BioVentures

Dyno Therapeutics develops artificial intelligence-powered genetic technologies for gene therapy, specifically engineering adeno-associated virus (AAV) capsids to improve gene delivery for treating genetic diseases.

AI & Machine LearningBiotechWatertown, US

Eric Kelsic(CEO & Cofounder)inSam Sinai(Vice President, Head of ML & Cofounder)inAdrian Veres(Chief Scientific Officer & Cofounder)George Church(Scientific Cofounder)Tomas Bjorklund(Scientific Co-founder)Alan Crane(Executive Chairman & Cofounder, Polaris Entrepreneur Partner)

Co-investorsAndreessen HorowitzCRV (Charles River Ventures)GENERAL INCEPTIONGV (Google Ventures)Lux CapitalObvious Ventures+2 more

Co-investorsHealthtech Capital

Co-investorsDCVC (Data Collective)

Epana Bio develops therapies for autoimmune diseases by leveraging genomics and AI to identify and target cellular origins of disease, with a focus on precision medicine for patient populations.

AI & Machine LearningBiotechDigital Health

Co-investorsBreakout LabsBreakout VenturesHAWKTAILHummingbird VenturesOMX VenturesRefactor Capital

Equii makes food products that combine complete protein with carbohydrates while reducing sugar, positioned around balanced nutrition.

ConsumerFoodTechWellness & Fitness

Monica Bhatia(Founder)in

Co-investorsAurum Venture PartnersVU Venture PartnersWestern Technology Investment

Exthymic is a company working on cell therapy manufacturing, aiming to make cancer cell therapies more accessible to patients who currently cannot obtain them.

BiotechHealthtechSan Diego, US

Rich Stoner(Executive Officer, Director)in

Index Biosystems builds an AI platform for food safety and quality assurance (FSQA) teams in food manufacturing, combining AI agents that automate investigations and audit prep with BioTags — food-grade, DNA-labeled microbial tracers that generate molecular data for tracing material movement and validating sanitation.

AI & Machine LearningBiotechFoodTechToronto, CA

Mike BorgDavid Singerin

Co-investorsUndeterred CapitalVanedge CapitalVanedge Capital Limited Partnership

MacroCycle uses a proprietary chemical process called SolvoGenesis, based on solvent systems and macrocyclic chemistry, to convert textile waste into pure polyester resin at low cost.

Circular EconomyCleantechNew MaterialsCambridge, US

Stwart Peña Feliz(Executive Officer, Director)inJan-Georg Rosenboom(Executive Officer, Director)

BoardCatia Cesari(Director)Temple Fennell(Director)

Co-investorsCircular Innovation FundNeotribe VenturesVolta CircleClean Energy VentureClean Energy VenturesCycle Capital

March Bioscience is a cell therapy company assembling leading scientists and drug developers to advance cell therapy treatments.

BiotechMedical DevicesHouston, US

Sarah Hein(CEO, Co-Founder)inMaksim Mamonkin(Co-Founder, Chair Scientific Advisory Board)Malcolm Brenner(Co-founder)

BoardThomas Luby(Director)inPeter Olagunju(Director)inJoseph Petrosino(Director)

Co-investorsMission Biocapital4BIO CapitalCancer FundFitz Gate VenturesModi VenturesPortal Innovations+1 more

Marigold Health operates an anonymous online community and app where people facing mental health or substance use challenges support each other, with some members receiving one-on-one help from certified Peer Recovery Coaches.

AI & Machine LearningDigital HealthMental Health

Shrenik Jain(Founder)in

Co-investorsBantam GroupDorm RoomEpsilon Health InvestorsFlare Capital PartnersStand Together Ventures LabTamarisc Ventures+3 more

BiotechSeattle, US

Bryce R Daines(Executive Officer, Director)Max C Darnell(Executive Officer, Director)

Co-investorsMadrona Venture Group

Co-investorsMadrona Venture Group

Molecule builds a blockchain-based ecosystem that connects scientists and entrepreneurs working on decentralized science projects, with a focus on AI-driven drug discovery and research funding.

AI & Machine LearningBiotechCrypto & Web3

Co-investorsFifty YearsInflection.xyzShine CapitalAME Cloud VenturesCherubic VenturesLunar Ventures

Motif Neurotech develops a therapeutic brain-computer interface using minimally invasive neuromodulation to treat difficult-to-treat mental health conditions such as depression.

BiotechDeep TechDigital HealthHealthtechMedical DevicesHouston, US

Sameer Sheth(Founder)inSunil Sheth(Founder)Nick Halper(Chief Operating Officer)inSteve Goetz(Chief Technology Officer)inAnthony Arnold(Director)

BoardJacob Robinson(Co-founder & CEO)in

Co-investorsArboretum VenturesPsyMed VenturesTMC Venture FundCapital FactoryDivergent CapitalDolby Family Ventures+2 more

Nosis develops a platform for receptor-targeted delivery of RNA therapeutics to specific cell types, addressing a key bottleneck in RNA drug development.

AI & Machine LearningBiotechDeep TechMedical Devices

Seth Myers(Founder)in

Co-investorsAlleyCorpMadrona Venture GroupAlley Robotics Ventures

Onc.AI develops the Onclara platform, which uses oncology real-world data to build predictive and prognostic AI models for cancer decision-making.

AI & Machine LearningBiotechDigital Health

Co-investorsLifeX VenturesDigitalis Ventures

AI-powered pathology for improved patient outcomes

Boston, US

ANDREW BECK(Executive Officer, Director)inADITYA KHOSLA(Executive Officer, Director)

BoardMICHELLE DIPP(Director)STANLEY LAPIDUS(Director)JEFF LEIDEN(Director)

Co-investors8VCBIOSPRING PARTNERSFairhaven Capital PartnersGeneral CatalystNimble PartnersOrbiMed+2 more

Perceptive applies AI and robotics technology to dental practice, helping dentists increase patient capacity.

AI & Machine LearningHealthtechMedical DevicesRoboticsBoston, US

Chris Ciriello(Founder)inScott Phillips(Founder)inPhil Getto(CTO)Alex Furleigh(Chief of Staff)

Co-investorsAngel Physicians FundDIANecessary VenturesTSVCY Combinator

PHNX Materials refines industrial waste and byproduct streams into critical metals such as gallium, germanium, and silicon, along with products for the building materials and agriculture industries.

Circular EconomyCleantechNew Materials

Rejuvenate Bio develops gene therapy treatments aimed at the root causes of aging to address chronic, age-related conditions such as osteoarthritis, heart disease, and cancer.

BiotechHealthtechLongevitySan Diego, US

Noah Davidsohn(CSO, Co-Founder)Daniel Oliver(CEO, Co-Founder)George Church(Co-Founder and SAB)Deborah Ascheim(Chief Medical Officer)

BoardDavid Zhu(Director)

Co-investorsCompanion FundConnecticut InnovationsDigitalis VenturesKendall Capital Partners

Reverb Therapeutics develops immunotherapies built on its Amplify•R platform, which modulates the body's natural immune system using targeted molecules such as IL-15-directed compounds.

BiotechHealthtech

BiotechWaltham, US

Ellen E. Sheets(Executive Officer, Director)

BoardCarl M. Berke(Director)Nancy Hong(Director)

Co-investorsBold Capital PartnersDigitalis VenturesRiverVest Venture Partners

Syenex provides cell delivery technologies and contract development services for therapeutic cell engineering, serving biopharmaceutical companies developing cell-based therapies.

BiotechDeep TechMedical DevicesEvanston, US

John D. Rosanelli(Executive Officer, Director)

Co-investorsAlleyCorpAlley Robotics Ventures

Tacit develops RNA repair technology called Splicing-Directed Repair, which uses naturally-occurring biological systems to fix genetic mutations as an alternative to conventional gene editing.

BiotechDeep TechHealthtech

Co-investorsEisai Innovation, Inc.Mitsui Global Investment

Terray Therapeutics develops small molecule drugs using its EMMI platform, which combines proprietary hardware, custom-generated datasets, and AI models for drug discovery.

AI & Machine LearningBiotechDeep Tech

Eli Berlin(Founder)in

Co-investorsDigitalis VenturesMadrona Venture Group

Theator builds an intelligence layer for surgery that turns video from minimally invasive procedures into usable data.

AI & Machine LearningDigital HealthHealthtechMedical DevicesPalo Alto, US

Dotan Asslemann(Director)Tamir Wolf(Executive Officer, Director)Dotan Asselmann(Founder)in

BoardGigi Levy Weiss(Director)in

Co-investorsBlumberg CapitalInsight PartnersNFXStageOne Ventures

Tierra Biosciences develops high-performance protein design technology, serving biotechnology and pharmaceutical industries.

Biotech

Co-investorsBeresford VenturesCreative VenturesFifty YearsFREEFLOWMaterial ImpactHumboldt+1 more

Co-investorsRaptor Group

ZymoChem develops bio-based materials using proprietary Carbon Conserving (C2) microbes that convert renewable feedstocks into high-value materials with increased yields.

BiotechCircular EconomyClimate TechNew MaterialsSan Leandro, US

Harshal Chokhawala(Founder & CEO)

Co-investorsAccelr8Breakout LabsBreakout VenturesCavallo VenturesDudley FundFreshTracks Capital+7 more